Crinetics Pharmaceuticals, Inc. (CRNX) › Operating IncomeCrinetics Pharmaceuticals, Inc. (CRNX) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2016: -$6.04M2017: -$9.13M2018: -$28.71M2019: -$53.83M2020: -$74.95M2021: -$107.70M2022: -$167.88M2023: -$222.61M2024: -$338.85M2025: -$516.77M-$516.77M2016Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$516.77M-52.5%2024-$338.85M-52.2%2023-$222.61M-32.6%2022-$167.88M-55.9%2021-$107.70M-43.7%2020-$74.95M-39.2%2019-$53.83M-87.5%2018-$28.71M-214.6%2017-$9.13M-51.0%2016-$6.04M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share